FIELD: chemistry.
SUBSTANCE: invention described herein relates to methods of obtaining macrolide antibacterial agents. In particular, invention relates to methods for preparing macrolides and ketolides from erythromycin A. Method of producing a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R10 is hydrogen or acyl; X is H; Y is OR7; where R7 is cladinose, alkyl or arylalkyl, or acyl or C(O)NR8R9, where each R8 and R9 is independently selected from a group, consisting of hydrogen, hydroxy, alkyl, alkoxy, aryl, aryalkyl, dimethylaminoalkyl, acyl, sulphonyl, ureido and carbamoyl; or R8 and R9 together with nitrogen atom attached thereto form a heterocycle; or X and Y together with a carbon atom attached thereto form a carbonyl; V is C(O), C(=NR11), CH(NR12, R13) or N(R14)CH2; where N(R14) is bonded to C-10 carbon atom; where R11 is a hydroxy or alkoxy; each R12 and R13 is independently selected from a group consisting of hydrogen, hydroxy, alkyl, alkoxy, aryl, aryalkyl, dimethylaminoalkyl, acyl, sulphonyl, ureido and carbamoyl; R14 is hydrogen, hydroxy, alkyl, alkoxy, aryl, arylalkyl, dimethylaminoalkyl, acyl, sulphonyl, ureido or carbamoyl; W denotes H, F, Cl, Br, I or OH; A is CH2, C(O), C(O)O, C(O)NH, S(O)2, S(O)2NH or C(O)NHS(O)2; B is (CH2)n, where n is an integer from 0 to 10; or unsaturated carbon chain, containing from 2 to 10 carbon atoms; and C is hydrogen, hydroxy, alkyl, alkoxy, aryl, arylalkyl, acyl, acyloxy, sulphonyl, ureido or carbamoyl; where alkyl independently in each case represents a C1-C30 alkyl; aryl in each case is independently selected from a group consisting of phenyl, optionally substituted amino group, naphthyl, pyridinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, quinolinyl, quinazolinyl, quinoxalinyl, thienyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, thiadiazolyl, triazolyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, benzisoxazolyl, benzisothiazolyl; acyl in each case is independently selected from a group consisting of C(O)alkyl and C(O)aryl, C(O)arylalkyl; involves (b) bringing a compound of formula (IV) or acid addition salt thereof, where R is a spatially hindered acyl group; and Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or tropyl; into contact with a methylating agent to obtain a compound of formula (V) or acid addition salt thereof; and (c) bringing compound of formula (V) or acid addition salt thereof into contact with deoximating agent to obtain a compound of formula (II) or acid addition salt thereof; and conversion of compound of formula (II) or acid addition salt thereof into a compound of formula (I) or a pharmaceutically acceptable salt thereof.
EFFECT: production of antibacterial agents.
32 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROBICYCLIC HEPATITIS C VIRUS (HCV) INHIBITORS | 2006 |
|
RU2405783C2 |
PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | 2013 |
|
RU2658050C2 |
METHOD FOR AMINO ACID COMPOUNDS OBTAINING | 2013 |
|
RU2643146C2 |
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF | 2010 |
|
RU2600736C2 |
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
PROTEIN PHOSPHATASE-1 INHIBITORS AND USING THEM | 2009 |
|
RU2527561C2 |
METHOD FOR PRODUCING MACROCYCLIC COMPOUNDS | 2006 |
|
RU2456296C2 |
PEPTIDE ANTIBIOTICS AND PRODUCTION METHODS THEREOF | 2005 |
|
RU2428429C2 |
METHOD FOR SYNTHESIS OF HYDRAZINE, WHICH CAN BE USED IN TREATMENT OF PAPILLOMA VIRUS | 2013 |
|
RU2649006C2 |
Authors
Dates
2017-01-18—Published
2011-05-20—Filed